Company: HMDCF
Filing Date: 2025-03-19
Form Type: 20-F
Source: 0001410578-25-000377
Chunk: 286

Company: HUTCHMED (China) Ltd
Filing Date: 2025-03-19
Form: 20-F
Item: Item 1
Chunk 286
---
 factors across the portfolio. Forward-looking estimates require the use of judgment, particularly in times of economic uncertainty.

Recent Accounting Pronouncements

See note 3 to our consolidated financial statements included in this annual report for information regarding recent accounting pronouncements.

Key Components of Results of Operations

The following tables set forth our selected consolidated financial data. We have derived the selected consolidated statements of operations data for the years ended December 31, 2024, 2023 and 2022 and the selected consolidated balance sheet data as of December 31, 2024 and 2023 from our audited consolidated financial statements, which were prepared in accordance with US GAAP and are included elsewhere in this annual report. The following selected consolidated financial data for the years ended December 31, 2021 and 2020 and as of December 31, 2022, 2021 and 2020 have been derived from our audited consolidated financial statements for those years, which were prepared in accordance with US GAAP and are not included in this annual report.

Table of Contents

                                                                                                      Year Ended December 31,                                                                      
                                                                                                                         2024             2023             2022             2021             2020  
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
                                                                                    $ ’ 000 (except share and per share data)                                                                      
  Consolidated statement of operations data:                                                                                                                                                       
  Revenue                                                                                                                                                                                          
  Goods — third parties                                                                                               401,382          388,924          314,329          266,199          203,606  
  — related parties                                                                                                     3,854            8,264            5,293            4,256            5,484  
  Services — commercialization — third parties                                                                         52,485           48,608           41,275           27,428            3,734  
  — research and development — related parties                                                                            471              481              507              525              491  
  — collaboration research and development — third parties                                                             57,968           80,397           23,741           18,995            9,771  
  Other collaboration revenue — royalties — third parties                                                              71,041           32,470           26,310           15,064            4,890  
  — licensing — third parties                                                                                          43,000          278